Keyword: World Health Organization
Merck's RotaTeq won China approval in April and a launch is underway, but meanwhile, the company is reducing its shipments to low-income countries.
Here is some other vaccine news of note for the week.
GSK touted data for what could be a promising vaccine against tuberculosis, a leading cause of death worldwide.
In what a WHO official described as "high community demand," 4,625 doses of Merck's Ebola vaccine, rVSV-ZEBOV, have been given in the latest outbreak.
China has withheld shipments of the H7N9 strain to the U.S. for research, according to The New York Times.
Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.
Merck and international agencies are preparing to roll out the experimental vaccine, hoping to stifle a new wave of cases that has killed 19 people.
WHO advisers said Sanofi's Dengvaxia should only be used after a diagnostic confirms a prior infection. But fast and reliable tests don't exist.
Here's some other vaccine news of note for the week.